Luisa L. Villa

Active 1986–2025

118
Papers
19,859
Citations
79
h-index
115
i10-index

Citations

Citations per year for Luisa L. Villa1987: 1 citations1988: 6 citations1989: 14 citations1990: 10 citations1991: 13 citations1992: 21 citations1993: 12 citations1994: 14 citations1995: 22 citations1996: 15 citations1997: 25 citations1998: 7 citations1999: 29 citations2000: 31 citations2001: 48 citations2002: 75 citations2003: 82 citations2004: 47 citations2005: 110 citations2006: 144 citations2007: 190 citations2008: 178 citations2009: 203 citations2010: 178 citations2011: 219 citations2012: 199 citations2013: 192 citations2014: 126 citations2015: 150 citations2016: 95 citations2017: 97 citations2018: 96 citations2019: 345 citations2020: 342 citations2021: 331 citations2022: 230 citations2023: 181 citations2024: 287 citations2025: 120 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,329 citing papers, 23.6% of this breakdownUnited Kingdom: 348 citing papers, 6.2% of this breakdownChina: 318 citing papers, 5.6% of this breakdownBrazil: 254 citing papers, 4.5% of this breakdownCanada: 247 citing papers, 4.4% of this breakdownFrance: 228 citing papers, 4% of this breakdownGermany: 203 citing papers, 3.6% of this breakdownItaly: 176 citing papers, 3.1% of this breakdownSpain: 168 citing papers, 3% of this breakdownAustralia: 163 citing papers, 2.9% of this breakdownNetherlands: 145 citing papers, 2.6% of this breakdownMexico: 139 citing papers, 2.5% of this breakdown
0%23.6%Other 34%

Fields

  • Medicine78.5%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Immunology and Microbiology6.1%
  • Agricultural and Biological Sciences0.9%
  • Engineering0.7%
  • Neuroscience0.7%
  • Other4%

Topics

  • Cervical Cancer and HPV Research21.9%
  • Genital Health and Disease6.3%
  • Head and Neck Cancer Studies6.1%
  • Hepatitis B Virus Studies4.9%
  • Reproductive tract infections research4.3%
  • Immunotherapy and Immune Responses3%
  • Other53.5%

Coauthors

All papers

Open in search
  1. Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studies

    Authors: , , , , - Oral Oncology 2021 cited by 126

  2. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2005 cited by 1,580

  3. Planning cancer control in Latin America and the Caribbean

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gilberto Lopes, Stephen Stefani, Marcelo Blaya, Fabiano Hahn Souza, Franklin Santana Santos, Alberto Kaemmerer, Evandro de Azambuja, Andres Felipe Cardona Zorilla, Raúl Murillo, José Jerónimo, Vivien Tsu, André Lopes Carvalho, Carlos Ferreira Gil, Cinthya Sternberg, Alfonso Dueñas‐González, Dennis C. Sgroi, Mauricio Cuello, Rodrigo Fresco, Rui Manuel Reis, Guiseppe Masera, Raúl Gabus, Raul C. Ribeiro, Renata Erthal Knust, Gustavo Ismael, Eduardo Rosenblatt, Berta Roth, Luisa L. Villa, Argelia Lara Solares, Marta León, Isabel Torres‐Vigil, Alfredo Covarrubias‐Gómez, Andrés Hernández, Mariela Bertolino, Gilberto Schwartsmann, Sergio Santillana, Francisco J. Esteva, Luis Fein, Max S. Mano, Henry Gómez, Marc Hurlbert, Alessandra Durstine, Gustavo S. Azenha - The Lancet Oncology 2013 cited by 504

  4. ICTV Virus Taxonomy Profile: Papillomaviridae

    Authors: , , , , , , , , , , - Journal of General Virology 2018 cited by 221

  5. B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses

    Authors: , , , , , , , , , - PLoS ONE 2018 cited by 113

  6. Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia

    Authors: , , , , , , , , - Cancer Epidemiology Biomarkers & Prevention 2006 cited by 343

  7. Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Vaccine 2022 cited by 32

  8. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study

    Authors: , , , , , , , , , , - The Lancet 2011 cited by 495

  9. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study

    Authors: , , , , , , , , , , - The Lancet 2013 cited by 278

  10. The role of inflammation in HPV carcinogenesis

    Authors: , , - Carcinogenesis 2010 cited by 193

  11. Expression of a novel non-coding mitochondrial RNA in human proliferating cells

    Authors: , , , , , , , , , , , - Nucleic Acids Research 2007 cited by 103

  12. Prevalence of HPV infection among sexually active adolescents and young adults in Brazil: The POP-Brazil Study

    Authors: , , , , , , , , , , , , , , , , , , - Scientific Reports 2020 cited by 72

  13. Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

    Authors: , , , , , , - The Journal of Infectious Diseases 1999 cited by 665

  14. The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Lupinacci, Katherine Giacoletti, Heather L. Sings, Margaret K. James, Teresa M. Hesley, Eliav Barr - The Journal of Infectious Diseases 2009 cited by 627

  15. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases

    Authors: , , , , - Vaccine 2006 cited by 571

  16. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Human Vaccines 2009 cited by 218

  17. Type‐Specific Duration of Human Papillomavirus Infection: Implications for Human Papillomavirus Screening and Vaccination

    Authors: , , , , , , , - The Journal of Infectious Diseases 2008 cited by 184

  18. HPV16 Tumor Associated Macrophages Suppress Antitumor T Cell Responses

    Authors: , , , - Clinical Cancer Research 2009 cited by 158

  19. Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Janine T. Bryan, Lisa Lupinacci, Katherine Giacoletti, Heather L. Sings, Margaret K. James, Teresa M. Hesley, Eliav Barr, Richard M. Haupt - JNCI Journal of the National Cancer Institute 2010 cited by 564

  20. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eliav Barr - Vaccine 2006 cited by 469

  21. A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roger Maansson, Shuang Lu, Scott Vuocolo, Teresa M. Hesley, Alfred J. Saah, Eliav Barr, Richard M. Haupt - Cancer Prevention Research 2009 cited by 328

  22. The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Lupinacci, Katherine Giacoletti, Margaret K. James, Scott Vuocolo, Teresa M. Hesley, Eliav Barr - The Journal of Infectious Diseases 2009 cited by 242

  23. Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cells

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 134

  24. HPV Vaccine: Updates and Highlights

    Authors: , , - Acta Cytologica 2019 cited by 104